Understanding Your Prescription Weight Loss Options
Wegovy Doses Compared to Mounjaro: Key Prescription Weight Loss Differences
When evaluating Wegovy doses compared to Mounjaro for prescription weight loss, the fundamental difference lies in their mechanisms and escalation schedules. Wegovy (semaglutide) is a GLP-1 receptor agonist that follows a structured 5-dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro (tirzepatide) operates as a dual GIP and GLP-1 receptor agonist with its own 4-dose pathway: 2.5mg starting dose, escalating through 5mg, 7.5mg, to 15mg maximum maintenance. Both prescription-only medicines require clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity.
The choice between these treatments often depends on individual response patterns and clinical factors that your prescriber will evaluate. Wegovy's single-hormone approach may suit patients seeking a well-established GLP-1 pathway, while Mounjaro's dual-hormone mechanism offers a different therapeutic approach. At EverydayMeds, our clinical team helps determine the most appropriate option based on your medical history, current health status, and weight management objectives through comprehensive prescriber review.
Wegovy and Mounjaro Pricing: Complete Cost Comparison for Weight Loss Treatment
Understanding the investment in prescription weight loss treatment is crucial when comparing Wegovy doses to Mounjaro options. Wegovy pricing at EverydayMeds starts with our 0.25mg starter dose at £79.99, progressing to 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). Our Getting Started bundles provide convenient dose progression: the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Duo (0.5mg & 1mg) is £189.99. New customers apply code FIRST40 at checkout, with returning customers using DOSE25 to reach these final prices.
Mounjaro follows a different pricing structure reflecting its distinct dosing pathway, with costs varying based on the prescribed strength and treatment duration. Both treatments represent significant investments in long-term weight management, typically requiring months of continuous therapy for optimal results. Our bundle options provide supply security and convenience, with the Ultimate Stability Trio offering three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment during the crucial maintenance phase.
Clinical Evidence: Wegovy Doses Compared to Mounjaro Weight Loss Outcomes
The clinical evidence supporting both treatments demonstrates impressive efficacy, though direct head-to-head comparisons between Wegovy doses and Mounjaro aren't available due to different trial designs and populations. In the landmark STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with STEP 5 showing sustained clinically studied weight loss at 2 years (Wilding et al., NEJM, 2021). The STEP 2 trial specifically examined patients with type 2 diabetes, showing approximately 9.6% weight reduction with the 2.4mg maintenance dose.
Mounjaro's SURMOUNT trials demonstrated the dual GIP/GLP-1 mechanism's potential, with various doses showing different efficacy profiles in their respective study populations. Both treatments require gradual dose escalation to minimise gastrointestinal side effects while building therapeutic efficacy. The key consideration isn't which treatment produces superior results, but rather which mechanism and dosing schedule aligns better with individual patient factors and tolerability profiles.
How Wegovy Works: GLP-1 Mechanism for Prescription Weight Loss
Wegovy's effectiveness in prescription weight loss stems from its role as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. Once injected weekly, semaglutide binds to GLP-1 receptors in the brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. This mechanism slows gastric emptying, meaning food remains in the stomach longer, contributing to prolonged satiety after smaller meal portions. The escalating dose schedule allows your body to adapt gradually, starting with 0.25mg to assess tolerance before progressing through higher strengths. Unlike quick-fix approaches, Wegovy works alongside lifestyle modifications to create sustainable appetite regulation and portion control habits that support long-term weight management success.
Ordering Process: Getting Started with Wegovy Through EverydayMeds
Beginning your prescription weight loss journey with Wegovy involves a streamlined three-step process designed for convenience and clinical safety. Our 3-minute online clinical assessment gathers essential medical history, current medications, and weight management goals to ensure appropriate prescribing. Following submission, our qualified prescribers review your assessment within standard 3 working days, or 24 hours with our express service for urgent cases. Once approved, your medication ships via next-day delivery using cold-chain, temperature-controlled packaging to maintain Wegovy's integrity from our GPhC #9012878 registered pharmacy. This process ensures every patient receives appropriate clinical oversight while accessing genuine, properly stored medication through legitimate UK pharmaceutical channels.
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Management
When comparing Wegovy doses to Mounjaro for prescription weight loss, practical storage differences significantly impact daily convenience. Wegovy offers superior travel flexibility with 6 weeks room temperature storage (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require refrigerator storage at 2-8°C before first use, but Wegovy's extended room temperature tolerance suits busy lifestyles, business travel, or holiday periods. The FlexTouch pen design provides consistent, reliable injection with clear dose markings and simple operation. Weekly injection timing remains flexible within 2-3 days of your scheduled day, allowing accommodation of changing schedules while maintaining therapeutic consistency throughout your weight management journey.
Wegovy Dose Escalation vs Mounjaro: Tailoring Prescription Weight Loss Progression
The dose escalation strategies represent a crucial difference when comparing Wegovy doses to Mounjaro for prescription weight loss treatment. Wegovy's 5-step escalation over 16 weeks provides gradual adaptation, allowing careful monitoring of both therapeutic response and side effect management at each level. This methodical approach helps identify your optimal therapeutic dose while minimising gastrointestinal disruption that can occur with faster escalation. Many patients find the 1.7mg dose provides excellent efficacy, though the 2.4mg maintenance dose remains the licensed target strength for maximum benefit.
Mounjaro's different escalation pattern reflects its dual-hormone mechanism, with dose adjustments based on individual response and tolerability. Neither approach is inherently superior; the choice depends on individual factors including previous GLP-1 experience, baseline health status, and personal preferences regarding injection frequency and dose progression. Your prescriber will evaluate these factors alongside your clinical assessment to recommend the most appropriate treatment pathway for your prescription weight loss goals.
Making Your Decision: Wegovy or Mounjaro for Weight Loss Success
Both Wegovy and Mounjaro represent excellent prescription weight loss options available through EverydayMeds, each offering unique advantages depending on individual circumstances. Wegovy's established efficacy profile, convenient storage characteristics, and structured dose progression make it suitable for patients seeking a proven GLP-1 approach with maximum flexibility. The treatment requires commitment to the full escalation schedule and ongoing maintenance dosing, typically extending 12+ months for sustainable results. Our comprehensive support includes ongoing prescriber access, delivery coordination, and clinical guidance throughout your treatment journey. Whether you choose Wegovy or Mounjaro, both treatments are available from EverydayMeds with the same clinical excellence and pharmaceutical standards our patients expect from a leading UK online pharmacy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
